Plain-English translation of NCT07470320 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
Researchers want to understand why some pregnancies develop serious complications like high blood pressure, gestational diabetes, or poor fetal growth. This study collects blood samples from pregnant women—both those with healthy pregnancies and those experiencing complications—to study tiny particles and proteins released by the placenta. By comparing these samples, scientists hope to find early warning signs and new treatment targets for pregnancy complications.
Conditions like pre-eclampsia, gestational diabetes, and fetal growth restriction can be dangerous for both mother and baby, but doctors don't yet have reliable early warning signs. This study aims to discover biological markers in the blood that could help doctors identify and treat these conditions sooner.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll visit the research clinic to provide blood samples—a routine procedure similar to a standard blood test. Researchers will compare your sample with others to understand how the placenta changes in healthy and complicated pregnancies. The study is observational, meaning researchers are watching and collecting information rather than giving you a medication or asking you to change your lifestyle.
AI-generated summary from trial data · Aug 3, 2026 · Not medical advice
United Kingdom